(Total Views: 170)
Posted On: 07/13/2023 8:45:46 AM
Post# of 62

$MBRX News Article - Moleculin Announces Publication of Data from Successful European Phase 1 Trial Evaluating Annamycin as Single Agent Treatment of Relapsed or Refractory Acute Myeloid Leukemia (AML) https://marketwirenews.com/news-releases/mole...05385.html


My Twitter: WhyteStocks